Primary Job Title CSO Primary Organization 
Remeditex Ventures
Location United States, North America Gender Male Also Known As Dennis Stone
Investor Type Investor Stage
Dennis has served as a member of the Board of Directors since September 2002. Dennis is Chief Scientific Officer and a Director of Remeditex Ventures LLC. He joined Remeditex in August 2011 from UT Southwestern Medical Center, or UTSW, where he was Professor of Internal Medicine, Physiology, and Biochemistry. He served as the Vice President of
Technology Development for UTSW from 1998 until July 2011. He has served on the board of directors of Eliance Biotechnologies, Inc., Myogen, Inc., miRagen Therapeutics, Inc., and MacroGenics, Inc. In addition, he served as the Chairman of the UT Regents’ Technology Transfer Commission, and he was vice chairman of the board of the Texas Emerging Technology Fund’s Life Science Commercialization Center. He received his undergraduate training at The University of Texas at Austin and his medical degree from UTSW.
